Differences in the lipoprotein distribution of free and liposome-associated all-trans-retinoic acid in human, dog, and rat plasma are due to variations in lipoprotein lipid and protein content
- PMID: 9660998
- PMCID: PMC105660
- DOI: 10.1128/AAC.42.7.1646
Differences in the lipoprotein distribution of free and liposome-associated all-trans-retinoic acid in human, dog, and rat plasma are due to variations in lipoprotein lipid and protein content
Abstract
The objective of the proposed study was to determine the distribution in plasma lipoprotein of free all-trans retinoic acid (ATRA) and liposomal ATRA (Atragen; composed of dimyristoyl phosphatidylcholine and soybean oil) following incubation in human, rat, and dog plasma. When ATRA and Atragen at concentrations of 1, 5, 10, and 25 micrograms/ml were incubated in human and rat plasma for 5, 60, and 180 min, the majority of the tretinoin was recovered in the lipoprotein-deficient plasma fraction. However, when ATRA and Afragen were incubated in dog plasma, the majority of the tretinoin (> 40%) was recovered in the high-density lipoprotein (HDL) fraction. No differences in the plasma distribution between ATRA and Atragen were found. These data suggest that a significant percentage of tretinoin associates with plasma lipoproteins (primarily the HDL fraction) upon incubation in human, dog, and rat plasma. Differences between the lipoprotein lipid and protein profiles in human plasma and in dog and rat plasma influenced the plasma distribution of ATRA and Atragen. Differences in lipoprotein distribution between ATRA and Atragen were not observed, suggesting that the drug's distribution in plasma in not influenced by its incorporation into these liposomes.
Figures


Similar articles
-
Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma.Antimicrob Agents Chemother. 1999 Jun;43(6):1424-8. doi: 10.1128/AAC.43.6.1424. Antimicrob Agents Chemother. 1999. PMID: 10348764 Free PMC article.
-
Preferential distribution of amphotericin B lipid complex into human HDL3 is a consequence of high density lipoprotein coat lipid content.J Pharm Sci. 1999 Nov;88(11):1149-55. doi: 10.1021/js990101z. J Pharm Sci. 1999. PMID: 10564063
-
Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins.Antimicrob Agents Chemother. 1998 Aug;42(8):1878-88. doi: 10.1128/AAC.42.8.1878. Antimicrob Agents Chemother. 1998. PMID: 9687378 Free PMC article.
-
Diversity of lipid-based polyene formulations and their behavior in biological systems.Eur J Clin Microbiol Infect Dis. 1997 Jan;16(1):81-92. doi: 10.1007/BF01575125. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9063678 Review.
-
Liposomal-all-trans-retinoic acid in treatment of acute promyelocytic leukemia.Leuk Lymphoma. 2002 May;43(5):933-41. doi: 10.1080/10428190290021678. Leuk Lymphoma. 2002. PMID: 12148903 Review.
Cited by
-
Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography.J Vet Med Sci. 2016 Sep 1;78(8):1277-81. doi: 10.1292/jvms.16-0052. Epub 2016 May 7. J Vet Med Sci. 2016. PMID: 27170431 Free PMC article.
-
Animal models for the atherosclerosis research: a review.Protein Cell. 2011 Mar;2(3):189-201. doi: 10.1007/s13238-011-1016-3. Epub 2011 Apr 6. Protein Cell. 2011. PMID: 21468891 Free PMC article. Review.
-
Sustained Drug Release From Liposomes for the Remodeling of Systemic Immune Homeostasis and the Tumor Microenvironment.Front Immunol. 2022 Apr 12;13:829391. doi: 10.3389/fimmu.2022.829391. eCollection 2022. Front Immunol. 2022. PMID: 35493504 Free PMC article.
-
Conservation in the phylum of the local homology of apolipoproteins with the thyroid hormone plasma carriers.Rev Endocr Metab Disord. 2016 Dec;17(4):537-544. doi: 10.1007/s11154-016-9379-7. Rev Endocr Metab Disord. 2016. PMID: 27549767 Review.
References
-
- Aten R F, Kolodecik T R, Behrman H R. Ovarian vitamin E accumulation: evidence for a role of lipoproteins. Endocrinology. 1994;135:533–539. - PubMed
-
- Brajtburg J, Elberg S, Medoff G. Interaction of plasma proteins and lipoproteins with amphotericin B. J Infect Dis. 1984;149:986–992. - PubMed
-
- Chabot G G, Pazdur R, Valeriote F A, Baker L H. Pharmacokinetics and toxicity of continuous infusion of amphotericin B in cancer patients. J Pharm Sci. 1989;78:307–310. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources